Howie Michael B, Michelsen Luis G, Hug Carl C, Porembka David T, Jopling Michael W, Warren Samuel M, Shaikh Soraya
Department of Anesthesiology, The Ohio State University Hospitals, Columbus, OH 43210, USA.
J Cardiothorac Vasc Anesth. 2003 Feb;17(1):51-9. doi: 10.1053/jcan.2003.10.
To identify the remifentanil dosing regimen providing safe and optimal anesthetic conditions during coronary artery bypass graft surgery and to evaluate postoperative recovery characteristics.
Open-label, randomized, parallel group.
Three centers in the United States.
Seventy-two patients with left ventricular stroke volumes >or=50 mL.
Patients were randomized to remifentanil doses of 1 microg/kg/min (group 1, n = 23); 2 microg/kg/min (group 2, n = 24), or 3 microg/kg/min (group 3, n = 25). Somatic, sympathetic, and hemodynamic responses indicating inadequate anesthesia were treated with bolus doses of remifentanil, 1 to 2 microg/kg, and infusion rate increases, and, if necessary, isoflurane 0.5% to 1.0% was added as a rescue anesthetic. In the intensive care unit, the remifentanil infusion was reset to 1 microg/kg/min, with midazolam administered for supplemental sedation and morphine for analgesia.
The durations of anesthesia, surgery, and cardiopulmonary bypass were similar for the 3 study groups. In addition, dose of lorazepam premedication, time to loss of consciousness, preoperative left ventricular ejection fraction, age, weight, and sex were similar for the 3 study groups. Remifentanil alone (infusion and boluses) prevented and controlled all responses to stimulation in 44% of group 3, 37% of group 2 and 9% of group 1 patients intraoperatively. Isoflurane (0.5%-1% inspired) rescue was successful in the remaining patients in each group. Hypotension indicating discontinuation of isoflurane and reductions of remifentanil infusion rates occurred in 64% to 75% of all patients. The optimal range of remifentanil infusion was 2 to 4 microg/kg/min with isoflurane to supplement the opioid. Fifty-one patients (71%) met the criteria for extubation within 6 hours postoperatively; because of surgical practice differences, only 30 patients (59%) were actually extubated.
After lorazepam premedication, remifentanil infusion (2-4 microg/kg/min) supplemented intermittently with low inspired concentrations of isoflurane provided an effective anesthetic regimen for coronary artery bypass graft surgery. Early extubation times were feasible after remifentanil continuous infusions (1-5 microg/kg/min) used as the primary anesthetic component intraoperatively and for analgesia (<or=1 microg/kg/min) in the immediate postoperative setting.
确定在冠状动脉搭桥手术期间提供安全且最佳麻醉条件的瑞芬太尼给药方案,并评估术后恢复特征。
开放标签、随机、平行组。
美国的三个中心。
72例左心室每搏量≥50 mL的患者。
患者被随机分为瑞芬太尼剂量为1微克/千克/分钟的组1(n = 23);2微克/千克/分钟的组2(n = 24),或3微克/千克/分钟的组3(n = 25)。对提示麻醉不足的躯体、交感神经和血流动力学反应,用1至2微克/千克的瑞芬太尼推注剂量和增加输注速率进行处理,必要时添加0.5%至1.0%的异氟烷作为补救麻醉剂。在重症监护病房,将瑞芬太尼输注重置为1微克/千克/分钟,给予咪达唑仑用于补充镇静,吗啡用于镇痛。
3个研究组的麻醉、手术和体外循环持续时间相似。此外,3个研究组的劳拉西泮术前用药剂量、意识消失时间、术前左心室射血分数、年龄、体重和性别相似。术中,仅瑞芬太尼(输注和推注)在组3的44%、组2的37%和组1的9%患者中预防和控制了对刺激的所有反应。每组其余患者的异氟烷(吸入浓度0.5%-1%)补救均成功。所有患者中有64%至75%出现提示停用异氟烷和降低瑞芬太尼输注速率的低血压。瑞芬太尼的最佳输注范围是2至4微克/千克/分钟,并使用异氟烷补充阿片类药物。51例患者(71%)在术后6小时内符合拔管标准;由于手术操作差异,实际仅30例患者(59%)拔管。
在劳拉西泮术前用药后,以低吸入浓度异氟烷间歇性补充的瑞芬太尼输注(2 - 4微克/千克/分钟)为冠状动脉搭桥手术提供了有效的麻醉方案。术中以瑞芬太尼持续输注(1 - 5微克/千克/分钟)作为主要麻醉成分且术后即刻用于镇痛(≤1微克/千克/分钟)后,早期拔管是可行的。